Vialwirebiotech, curated
October 1, 2026, 7:01 PM
July 9, 2026
- 4:53 PM · BioPharma Dive4:53 PMRoche scraps two Ionis-partnered Huntington’s drugs — BioPharma Dive
- 12:31 PM · FT — Pharmaceuticals12:31 PMAstraZeneca shares slide after heart treatment disappoints in trial — FT — Pharmaceuticals
- 12:11 PM · Pharmaceutical Technology12:11 PMModerna secures up to 24 million RSV vaccine dose contract with Europe — Pharmaceutical Technology
- 12:00 PM · BioWorld12:00 PMForte, First Tracks soar on CD122 success in vitiligo; celiac next — BioWorld
- 11:45 AM · BioPharma Dive11:45 AMGSK ends brain drug alliance with Alector — BioPharma Dive
- 11:00 AM · STAT News11:00 AMSTAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs — STAT News
- 9:47 AM · Pharmaceutical Executive9:47 AM<![CDATA[FDA Approves Ennumo to Decrease Incidence of Infection by Febrile Neutropenia ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMPromomed Rus discovers new JAK inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMU&S Bio identifies new H+/K+-ATPase inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMPrelude Therapeutics patents new KAT6A-targeting PROTACs — BioWorld
- 9:00 AM · BioWorld9:00 AMUrogen’s UGN-501 gains IND clearance for bladder cancer — BioWorld
- 9:00 AM · BioWorld9:00 AMNuvalent discloses new AKT1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMGrant supports Rybodyn’s antibody therapies for lung cancer — BioWorld
- 9:00 AM · BioWorld9:00 AMApolin Bio and Viva Biotech present new ApoA/APOB interaction inhibitors — BioWorld
- 7:48 AM · FT — Pharmaceuticals7:48 AMLeading UK research facility Diamond Light Source faces cost cuts — FT — Pharmaceuticals
- 6:30 AM · STAT News6:30 AMSTAT+: 931 days. The drug approval scandal hiding in plain sight — STAT News
- 5:13 AM · STAT News5:13 AMSTAT+: AstraZeneca, Ionis report major trial failure with heart disease drug — STAT News
- 5:07 AM · Pharmaceutical Technology5:07 AMEvogene and Tel Aviv University launch drug discovery initiative — Pharmaceutical Technology
July 8, 2026
- 2:51 PM · STAT News2:51 PMSTAT+: White House reviewing top contenders to lead FDA — STAT News
- 12:00 PM · BioWorld12:00 PMPhase II DMD Trailhead data hike Satellos’ stock — BioWorld
- 12:00 PM · BioWorld12:00 PMSeres’ SER-155 takes on immune checkpoint inhibitor-related enterocolitis — BioWorld
- 10:44 AM · Pharmaceutical Executive10:44 AM<![CDATA[Novartis to Layoff 322 NJ Employees: Report]]> — Pharmaceutical Executive
- 9:52 AM · STAT News
- 9:00 AM · BioWorld9:00 AMFDA clears IND for LTZ Therapeutics’ LTZ-232 — BioWorld
- 9:00 AM · BioWorld9:00 AMCoregen’s CRG-150 gains IND clearance for solid tumors — BioWorld
- 9:00 AM · BioWorld9:00 AMART-5 cleared for clinic in China for polycystic kidney disease — BioWorld
- 6:40 AM · Pharmaceutical Technology6:40 AMKalohexis confidentially files IPO to back obesity and cachexia portfolio — Pharmaceutical Technology
- 6:11 AM · Pharmaceutical Technology6:11 AMNovo Nordisk signs pact with Vivani for long-lasting semaglutide implant — Pharmaceutical Technology
- 5:15 AM · Pharmaceutical Technology5:15 AMFDA grants rare paediatric designation to Vanda’s CMT2S therapy — Pharmaceutical Technology
- 3:59 AM · Pharmaceutical Technology3:59 AMBiocytogen and Whitehawk partner to develop ADCs — Pharmaceutical Technology